Lindbrook Capital’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $9.54K | Sell |
758
-47
| -6% | -$591 | ﹤0.01% | 1675 |
|
|
2024
Q4 | $8.49K | Sell |
805
-50
| -6% | -$528 | ﹤0.01% | 1734 |
|
|
2024
Q3 | $12.4K | Sell |
855
-6
| -0.7% | -$87 | ﹤0.01% | 1557 |
|
|
2024
Q2 | $7.33K | Buy |
861
+161
| +23% | +$1.37K | ﹤0.01% | 1806 |
|
|
2024
Q1 | $7.15K | Hold |
700
| – | – | ﹤0.01% | 1738 |
|
|
2023
Q4 | $3.84K | Buy |
700
+491
| +235% | +$2.69K | ﹤0.01% | 2024 |
|
|
2023
Q3 | $790 | Buy |
+209
| New | +$790 | ﹤0.01% | 2420 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2856 |
|